Apar Kishor Ganti, MD

Apar Kishor Ganti, MD

Apar Kishor Ganti, MD
Professor, Internal Medicine
Division of Oncology & Hematology

Academic office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax. 402-559-6520

Practice location:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Education:
B.J. Medical College, University of Pune, India, Medical School, 1990-1996
B.J. Medical College, University of Pune, India, Residency (Clinical Pharmacology), 1996-1999
University of North Dakota School of Medicine, Fargo, ND, Internship, 2000-2001
University of North Dakota School of Medicine, Fargo, ND, Residency (Internal Medicine), 2001-2003
University of Nebraska Medical Center, Omaha, NE, Fellowship, (Oncology/Hematology), 2003-2005

Hospital Appointments:
Nebraska Medicine
VA Nebraska-Western Iowa Health Care System

Interests:
Lung, Head and Neck Cancers

Biographical Sketch:
Dr. Apar Kishor Ganti is a Professor in the Department of Internal Medicine, Division of Oncology/Hematology, at the University of Nebraska Medical Center. He received his medical degree in 1996 from B.J. Medical College, University of Pune, India, and served a residency in Clinical Pharmacology at B.J. Medical College, University of Pune, from 1996-1999. Dr. Ganti completed his Internship (2000 to 2001) in Internal Medicine Residency (2001 to 2003), at the University of North Dakota School of Medicine in Fargo, ND. From 2003-2005, Dr. Ganti was an Oncology/Hematology fellow at the University of Nebraska Medical Center, in Omaha, NE

Currently, Dr.  Ganti is actively engaged in medical practice, teaching and clinical research and specialize in the care of patients with head and neck, including thyroid, and lung cancer at the Omaha VA Medical Center and the University of Nebraska Medical Center. He is a member of the Respiratory Committee of the Alliance for Clinical Trials In Oncology, which is responsible for designing clinical trials in lung cancer. He is the Health Outcomes Committee Chair of a couple of NCTN clinical trials, one in limited stage small cell lung cancer and another in adjuvant treatment of non-small cell lung cancer. He is the Chair of the Small Cell Lung Cancer Committee of the National Comprehensive Cancer Network. His research interests are focused on development of clinical trials evaluating newer treatment approaches for patients who are not candidates for standard therapies. His laboratory is also focused on evaluating new pathways in head and neck and lung cancer and identifying novel prognostic and predictive biomarkers for these malignancies. They have developed novel spontaneous animal models of lung cancer, which closely resemble human malignancy and are currently investigating the biology of lung cancer in those models.

Dr. Ganti is also very active within the VA Oncology community. He is the Chair of the VA Oncology Field Advisory Board that advises the National Program Director in Oncology on issues relevant to oncology care in the veteran population across the country. He is a member of the VA Precision Oncology Program Advisory Committee and the VA Clinical Science Research & Development Centralized Data Monitoring Committee. Dr. Ganti is the recipient of a VA BLR&D Merit Review to study the effect of MUC5AC in brain metastases in lung cancer. 

Publications:

Publications at PubMed.Gov:https://pubmed.ncbi.nlm.nih.gov/?term=Ganti+AK